Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Chloe I, Bloom"'
Autor:
Lydia WY Fung, Vincent KC Yan, Christine Kwan, WC Kwok, David CL Lam, Christine F McDonald, Chloe I Bloom, Ian CK Wong, Esther W Chan
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Excessive use of short-acting β2 agonists (SABA) in patients with asthma continues to be a notable concern due to its link to higher mortality rates. Global relevance of SABA overuse in asthma management cannot be understated, it
Externí odkaz:
https://doaj.org/article/87da752cb1ce49a9806b5e06896a6af4
Autor:
Chris Wai Hang Lo, Swathi Pathadka, Simon Xiwen Qin, Lydia W.Y. Fung, Vincent Ka Chun Yan, Hei Hang Edmund Yiu, Chloe I. Bloom, Ian Chi Kei Wong, Esther Wai Yin Chan
Publikováno v:
European Respiratory Review, Vol 32, Iss 169 (2023)
Background: The United States Food and Drug Administration issued a black box warning on the mental health adverse effects of montelukast in 2020. Age-related effects on the risk of developing specific neuropsychiatric events in montelukast users rem
Externí odkaz:
https://doaj.org/article/138b9bc637fd4df583f3ce08932e968b
Autor:
Eleanor L. Axson, Kishan Ragutheeswaran, Varun Sundaram, Chloe I. Bloom, Alex Bottle, Martin R. Cowie, Jennifer K. Quint
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Background Discrepancy exists amongst studies investigating the effect of comorbid heart failure (HF) on the morbidity and mortality of chronic obstructive pulmonary disease (COPD) patients. Methods MEDLINE and Embase were searched using a p
Externí odkaz:
https://doaj.org/article/a26e3f670e0041b9b8741b60b31e12b5
Autor:
Onn Min Kon, Chloe I Bloom, Felicity Liew, Kartik Kumar, Clare Ross, laura Martin, Jian Chen, Jamilah Meghji, Dominic Hampson, Patrick Mallia, Brandon Wong, Victoria Pilkington, Shaan Chhabra, Ben Russell, Karthikan Srikanthan, Mirae Park, Harriet Owles, Joana Alcada, Meg Coleman, Sarah Elkin, Shweta Agrawal, Thomas Gardiner, Aaron Bell, Alice White, Gauri Vithlani, Kavina Manalan, Solange Bramer, Alejandra Martin Segura, Anushree Kucheria, Prashanthi Ratnakumar, Alexander Sheeka, Lavanya Anandan, Susan Copley, Georgina Russell
Publikováno v:
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
Background The symptoms, radiography, biochemistry and healthcare utilisation of patients with COVID-19 following discharge from hospital have not been well described.Methods Retrospective analysis of 401 adult patients attending a clinic following a
Externí odkaz:
https://doaj.org/article/4855008fd2cf4c1782dab10fc127cd2f
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background Oral corticosteroid use increases the risk of systemic adverse effects including osteoporosis, bone fractures, diabetes, ocular disorders and respiratory infections. We sought to understand if inhaled corticosteroid (ICS) use in asthma is
Externí odkaz:
https://doaj.org/article/ec5d23294aa842c396cd463c2a8d6d1f
Publikováno v:
PLoS Medicine, Vol 17, Iss 7, p e1003145 (2020)
BackgroundGuidelines recommend stepping down asthma treatment to the minimum effective dose to achieve symptom control, prevent adverse side effects, and reduce costs. Limited data exist on asthma prescription patterns in a real-world setting. We aim
Externí odkaz:
https://doaj.org/article/e9e14e11079d40bb8e48197d1f1d0bae
Publikováno v:
Pulmonary Therapy. 8:75-93
Previous studies have reported that more patients receive inhaled corticosteroid (ICS)-containing therapies than would be expected based on exacerbation history, suggesting overprescribing. We aimed to describe patterns of treatment switching from fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79e972fbbfbfda285574546c193fcf5f
https://doi.org/10.1007/s41030-021-00180-7
https://doi.org/10.1007/s41030-021-00180-7
Autor:
Chloe I. Bloom
This review addresses some of the major lessons we have learnt regarding asthma and the covid-19 pandemic, including susceptibility to SARS-CoV-2 infection and severe covid-19, potentially protective factors, comparison to other respiratory infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2ad573f13123de16deba2e0a619aba
http://hdl.handle.net/10044/1/104448
http://hdl.handle.net/10044/1/104448
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-3 (2021)
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine
In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ad0b7fd5613b3faa8426681542c593
https://doaj.org/article/99c9f829409e414997ec3099d23cce9c
https://doaj.org/article/99c9f829409e414997ec3099d23cce9c
Publikováno v:
American journal of respiratory and critical care medicine. 206(6)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic. People with airways disease are at higher risk of respiratory infection, and viruses can trigger respiratory exacerbations. Patients with airways disease ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604b5efa9ecadaf9a12d24506f686d0d
https://pubmed.ncbi.nlm.nih.gov/35737585
https://pubmed.ncbi.nlm.nih.gov/35737585